105 related articles for article (PubMed ID: 10648642)
1. Basic fibroblast growth factor sensitizes NIH 3T3 cells to apoptosis induced by cisplatin.
Coleman AB; Momand J; Kane SE
Mol Pharmacol; 2000 Feb; 57(2):324-33. PubMed ID: 10648642
[TBL] [Abstract][Full Text] [Related]
2. Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells.
Wang Q; Maloof P; Wang H; Fenig E; Stein D; Nichols G; Denny TN; Yahalom J; Wieder R
Exp Cell Res; 1998 Jan; 238(1):177-87. PubMed ID: 9457070
[TBL] [Abstract][Full Text] [Related]
3. Suramin interrupts androgen-inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (Shionogi carcinoma 115) cells.
Kasayama S; Saito H; Kouhara H; Sumitani S; Sato B
J Cell Physiol; 1993 Feb; 154(2):254-61. PubMed ID: 7678839
[TBL] [Abstract][Full Text] [Related]
4. Cell motility, invasion, and malignancy induced by overexpression of K-FGF or bFGF.
Taylor WR; Greenberg AH; Turley EA; Wright JA
Exp Cell Res; 1993 Feb; 204(2):295-301. PubMed ID: 8440326
[TBL] [Abstract][Full Text] [Related]
5. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
[TBL] [Abstract][Full Text] [Related]
6. [The inhibiting effects of suramin on bFGF induced proliferation of cultured human RPE cells].
Zhu XB; Tang SB; Luo Y; Huang XK
Zhonghua Yan Ke Za Zhi; 2005 Feb; 41(2):110-3. PubMed ID: 15840333
[TBL] [Abstract][Full Text] [Related]
7. Release of bFGF following apoptosis and necrosis in NSCLC cells: effects on chemosensitivity to cisplatin.
Kuhn H; Weser L; Gessner C; Hammerschmidt S; Wirtz H
Oncol Rep; 2005 Sep; 14(3):759-62. PubMed ID: 16077988
[TBL] [Abstract][Full Text] [Related]
8. Reversal of basic fibroblast growth factor-mediated autocrine cell transformation by aromatic anionic compounds.
Benezra M; Vlodavsky I; Yayon A; Bar-Shavit R; Regan J; Chang M; Ben-Sasson S
Cancer Res; 1992 Oct; 52(20):5656-62. PubMed ID: 1394189
[TBL] [Abstract][Full Text] [Related]
9. Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin.
Moscatelli D; Quarto N
J Cell Biol; 1989 Nov; 109(5):2519-27. PubMed ID: 2553749
[TBL] [Abstract][Full Text] [Related]
10. Lidamycin inhibits the cancer cell PKC activity induced by basic fibroblast growth factor.
Zhen HY; Huang YH; Zhen YS
Yao Xue Xue Bao; 2005 Dec; 40(12):1110-5. PubMed ID: 16496675
[TBL] [Abstract][Full Text] [Related]
11. Chemoresistance of endothelial cells induced by basic fibroblast growth factor depends on Raf-1-mediated inhibition of the proapoptotic kinase, ASK1.
Alavi AS; Acevedo L; Min W; Cheresh DA
Cancer Res; 2007 Mar; 67(6):2766-72. PubMed ID: 17363598
[TBL] [Abstract][Full Text] [Related]
12. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation.
Dhandapani KM; Khan MM; Wade FM; Wakade C; Mahesh VB; Brann DW
J Neurosci Res; 2007 Apr; 85(5):1033-45. PubMed ID: 17335076
[TBL] [Abstract][Full Text] [Related]
13. Chemosensitization by fibroblast growth factor-2 is not dependent upon proliferation, S-phase accumulation, or p53 status.
Coleman AB; Metz MZ; Donohue CA; Schwarz RE; Kane SE
Biochem Pharmacol; 2002 Oct; 64(7):1111-23. PubMed ID: 12234614
[TBL] [Abstract][Full Text] [Related]
14. Effects of basic fibroblast growth factor on endothelial cells under conditions of simulated microgravity.
Ulbrich C; Westphal K; Baatout S; Wehland M; Bauer J; Flick B; Infanger M; Kreutz R; Vadrucci S; Egli M; Cogoli A; Derradji H; Pietsch J; Paul M; Grimm D
J Cell Biochem; 2008 Jul; 104(4):1324-41. PubMed ID: 18253936
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
Reddy RM; Tsai WS; Ziauddin MF; Zuo J; Cole GW; Maxhimer JB; Fang B; Schrump DS; Nguyen DM
J Thorac Cardiovasc Surg; 2004 Dec; 128(6):883-91. PubMed ID: 15573073
[TBL] [Abstract][Full Text] [Related]
16. Activation of telomerase and cyclooxygenase-2 in PDGF and FGF inhibition of C2-ceramide-induced apoptosis.
Chien CC; Shen SC; Yang LY; Wu CY; Liau JS; Chen YC
J Cell Physiol; 2009 Feb; 218(2):405-15. PubMed ID: 18932216
[TBL] [Abstract][Full Text] [Related]
17. Stimulatory effect of basic fibroblast growth factor on induction of heat shock protein 27 in osteoblasts: role of protein kinase C.
Kozawa O; Niwa M; Matsuno H; Ishisaki A; Kato K; Uematsu T
Arch Biochem Biophys; 2001 Apr; 388(2):237-42. PubMed ID: 11368160
[TBL] [Abstract][Full Text] [Related]
18. Elemene displays anti-cancer ability on laryngeal cancer cells in vitro and in vivo.
Tao L; Zhou L; Zheng L; Yao M
Cancer Chemother Pharmacol; 2006 Jul; 58(1):24-34. PubMed ID: 16283311
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules.
Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Kato T; Hamada H; Nishioka K
Arthritis Rheum; 2000 May; 43(5):1106-14. PubMed ID: 10817565
[TBL] [Abstract][Full Text] [Related]
20. Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumors.
Zhang Y; Song S; Yang F; Au JL; Wientjes MG
J Pharmacol Exp Ther; 2001 Nov; 299(2):426-33. PubMed ID: 11602651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
